Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage adaptation to hypoxia in the tuberculous granuloma potentiates mycobacterium-induced mitochondrial damage and granuloma necrosis.

bioRxiv : the preprint server for biology·2026
Same author

Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial.

Nature medicine·2026
Same author

Mycobacteria trehalose dimycolate interactions with host Mincle remodel blood-brain barrier junctions for brain invasion.

Cell reports·2025
Same author

Structural and functional analysis of the <i>Mycobacterium tuberculosis</i> MmpS5L5 efflux pump presages increased bedaquiline resistance.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Structural and functional analysis of the <i>Mycobacterium tuberculosis</i> MmpS5L5 efflux pump presages a pathway to increased bedaquiline resistance.

bioRxiv : the preprint server for biology·2025
Same author

Verapamil and its metabolite norverapamil inhibit the <i>Mycobacterium tuberculosis</i> MmpS5L5 efflux pump to increase bedaquiline activity.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: May 20, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

An in vivo platform for rapid high-throughput antitubercular drug discovery.

Kevin Takaki1, Christine L Cosma, Mark A Troll

  • 1Department of Microbiology, University of Washington, Seattle, WA 98195, USA.

Cell Reports
|July 31, 2012
PubMed
Summary

This study introduces a zebrafish model for rapid drug screening against tuberculosis. The platform identifies new antibacterial drugs and synergistic drug combinations, aiding drug discovery for infectious diseases.

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Experiment Videos

Last Updated: May 20, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Area of Science:

  • Microbiology
  • Pharmacology
  • Zebrafish disease models

Background:

  • Drug resistance is a major challenge in treating tuberculosis and other infectious diseases.
  • Existing drug discovery methods lack the complexity of human disease, hindering progress.
  • Tuberculosis pathogenesis and drug treatment can be recapitulated in Mycobacterium marinum-infected zebrafish larvae.

Purpose of the Study:

  • To develop a rapid in vivo drug screening model using zebrafish larvae.
  • To enable quantitative assessment of drug efficacy and toxicity.
  • To facilitate the discovery of novel antitubercular agents and drug combinations.

Main Methods:

  • Utilized Mycobacterium marinum-infected zebrafish larvae as a disease model.
  • Employed fluorescence-based methods for serial quantitative assessment.
  • Screened both traditional antibacterial and host-targeting compounds.

Main Results:

  • Demonstrated proof-of-concept for discovering traditional and novel host-targeting drugs.
  • Identified synergistic combinations of antibacterial drugs.
  • Showcased synergy between bacterial- and host-targeting compounds.

Conclusions:

  • The developed zebrafish model offers a rapid platform for in vivo drug screening.
  • This model can identify new antibacterial agents and novel drug classes targeting host pathways.
  • The methodology is broadly applicable to drug discovery for various infectious and noninfectious diseases.